Clearmind Medicine Inc. Proceeds From Issue Of Ordinary Shares
Clearmind Medicine Inc. (CMND) reported Proceeds From Issue Of Ordinary Shares of $2.19 million for the 12-month period ending 2024-10-31, per its 20-F filed 2026-01-20.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromIssueOfOrdinaryShares · last filed 2026-01-20
- Clearmind Medicine Inc. proceeds from issue of ordinary shares for the quarter ending 2024-10-31 was $367.67K, a 79.74% decline year-over-year.
- Clearmind Medicine Inc. proceeds from issue of ordinary shares for the quarter ending 2024-07-31 was $0.00.
- Clearmind Medicine Inc. proceeds from issue of ordinary shares for the quarter ending 2024-04-30 was $0.00, a 100.00% decline year-over-year.
- Clearmind Medicine Inc. proceeds from issue of ordinary shares for the quarter ending 2024-01-31 was $1.82M, a 71.33% decline year-over-year.
| Period end | Proceeds From Issue Of Ordinary Shares 3 month | Proceeds From Issue Of Ordinary Shares 6 month | Proceeds From Issue Of Ordinary Shares 6 month as first filed | Proceeds From Issue Of Ordinary Shares 9 month | Proceeds From Issue Of Ordinary Shares 12 month |
|---|---|---|---|---|---|
| 2024-10-31 | $367.67K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $367.67K derived: sum of 2 quarters · filed 2026-01-20 | $367.67K derived: sum of 3 quarters · filed 2026-01-20 | $2.19M 20-F · filed 2026-01-20 | |
| 2024-07-31 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $0.00 derived: sum of 2 quarters · filed 2025-09-11 | $1.82M 6-K · filed 2025-09-11 | $3.64M derived: sum of 4 quarters · filed 2026-01-20 | |
| 2024-04-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | $1.82M 6-K · filed 2025-06-12 | $3.64M derived: sum of 3 quarters · filed 2026-01-20 | $3.62M derived: sum of 4 quarters · filed 2026-01-20 | |
| 2024-01-31 | $1.82M 6-K · filed 2025-03-13 | $3.64M derived: sum of 2 quarters · filed 2026-01-20 | $3.62M derived: sum of 3 quarters · filed 2026-01-20 | $6.58M derived: sum of 4 quarters · filed 2026-01-20 | |
| 2023-10-31 | $1.82M derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $1.79M derived: sum of 2 quarters · filed 2026-01-20 | $4.75M derived: sum of 3 quarters · filed 2026-01-20 | $11.12M 20-F · filed 2026-01-20 | |
| 2023-07-31 | -$21.75K derived: 6-K 9 month − 6-K 6 month · filed 2024-09-16 | $2.94M derived: sum of 2 quarters · filed 2024-09-16 | $9.30M 6-K · filed 2024-09-16 | ||
| 2023-04-30 | $2.96M derived: 6-K 6 month − 6-K 3 month · filed 2024-06-13 | $9.32M 6-K · filed 2024-06-13 | $6.36M 6-K · filed 2023-06-14 | ||
| 2023-01-31 | $6.36M 6-K · filed 2024-03-19 | ||||
| 2022-10-31 | $582.56K 20-F · filed 2025-01-22 | ||||
| 2021-10-31 | $5.39M 20-F/A · filed 2024-03-18 |